118 related articles for article (PubMed ID: 9157070)
1. Effects of 13-hydroxy SM5887 in combination with other anticancer agents on human tumor cell lines.
Takagi T; Yazawa Y; Suzuki K; Yamauchi Y; Kano Y
Invest New Drugs; 1996; 14(4):357-63. PubMed ID: 9157070
[TBL] [Abstract][Full Text] [Related]
2. Effects of 4-hydroperoxy ifosfamide in combination with other anticancer agents on human cancer cell lines.
Yazawa Y; Takagi T; Asakura S; Suzuki K; Kano Y
J Orthop Sci; 1999; 4(3):231-7. PubMed ID: 10370165
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
[TBL] [Abstract][Full Text] [Related]
4. In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.
Kano Y; Akutsu M; Tsunoda S; Suzuki K; Ichikawa A; Furukawa Y; Bai L; Kon K
Leukemia; 2000 Mar; 14(3):379-88. PubMed ID: 10720130
[TBL] [Abstract][Full Text] [Related]
5. Effects of carboplatin in combination with other anticancer agents on human leukemia cell lines.
Kano Y; Akutsu M; Suzuki K; Yoshida M
Leuk Res; 1993 Feb; 17(2):113-9. PubMed ID: 8429687
[TBL] [Abstract][Full Text] [Related]
6. [Effects of SN-38 in combination with other anticancer agents against Dauji cells].
Akutsu M; Suzuki K; Tsunoda S; Kano Y; Miura Y
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1607-11. PubMed ID: 8060135
[TBL] [Abstract][Full Text] [Related]
7. [Effects of carboplatin combination with etoposide against leukemia/lymphoma cell lines].
Akutsu M; Suzuki K; Tsunoda S; Kano Y
Gan To Kagaku Ryoho; 1996 Feb; 23(3):297-302. PubMed ID: 8712822
[TBL] [Abstract][Full Text] [Related]
8. Effects of amsacrine in combination with other anticancer agents in human acute lymphoblastic leukemia cells in culture.
Kano Y; Sakamoto S; Kasahara T; Akutsu M; Inoue Y; Miura Y
Leuk Res; 1991; 15(11):1059-66. PubMed ID: 1961009
[TBL] [Abstract][Full Text] [Related]
9. The effects of ICRF-154 in combination with other anticancer agents in vitro.
Kano Y; Narita T; Suzuki K; Akutsu M; Suda K; Sakamoto S; Miura Y
Br J Cancer; 1992 Aug; 66(2):281-6. PubMed ID: 1503899
[TBL] [Abstract][Full Text] [Related]
10. Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro.
Akutsu M; Furukawa Y; Tsunoda S; Izumi T; Ohmine K; Kano Y
Leukemia; 2002 Sep; 16(9):1808-17. PubMed ID: 12200697
[TBL] [Abstract][Full Text] [Related]
11. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture.
Kano Y; Ohnuma T; Okano T; Holland JF
Cancer Res; 1988 Jan; 48(2):351-6. PubMed ID: 3422052
[TBL] [Abstract][Full Text] [Related]
12. Effects of mitoxantrone in combination with other anticancer agents on a human leukemia cell line.
Kano Y; Suzuki K; Akutsu M; Suda K
Leukemia; 1992 May; 6(5):440-5. PubMed ID: 1593909
[TBL] [Abstract][Full Text] [Related]
13. Effects of CPT-11 in combination with other anti-cancer agents in culture.
Kano Y; Suzuki K; Akutsu M; Suda K; Inoue Y; Yoshida M; Sakamoto S; Miura Y
Int J Cancer; 1992 Feb; 50(4):604-10. PubMed ID: 1537625
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antitumor activity of new anthracycline analogues, ME2303, KRN8602, and SM5887 using human lung cancer cell lines.
Takigawa N; Ohnoshi T; Ueoka H; Kiura K; Kimura I
Acta Med Okayama; 1992 Aug; 46(4):249-56. PubMed ID: 1442149
[TBL] [Abstract][Full Text] [Related]
15. Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines.
Klaassen U; Harstrick A; Schleucher N; Vanhoefer U; Schröder J; Wilke H; Seeber S
Br J Cancer; 1996 Jul; 74(2):224-8. PubMed ID: 8688325
[TBL] [Abstract][Full Text] [Related]
16. [Combination effects of etoposide with other antitumor drugs in vitro and in vivo].
Nishikawa K; Kusama K; Ekimoto H; Takahashi K
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3739-45. PubMed ID: 2596858
[TBL] [Abstract][Full Text] [Related]
17. Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines.
Viale M; Pastrone I; Pellecchia C; Vannozzi MO; Cafaggi S; Esposito M
Anticancer Drugs; 1998 Jun; 9(5):457-63. PubMed ID: 9660544
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.
Kano Y; Akutsu M; Tsunoda S; Izumi T; Kobayashi H; Mano H; Furukawa Y
Invest New Drugs; 2007 Feb; 25(1):31-40. PubMed ID: 16865529
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
20. Schedule-dependent synergism and antagonism between raltitrexed ("Tomudex") and methotrexate in human colon cancer cell lines in vitro.
Kano Y; Akutsu M; Tsunoda S; Suzuki K; Yazawa Y; Furukawa Y
Jpn J Cancer Res; 2001 Jan; 92(1):74-82. PubMed ID: 11173547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]